.svg){kind=small}
Where to Buy
Dreamt is stocked at 38 licensed dispensaries across Colorado, Virginia, and 5 other states, 13 of them in Colorado, with the deepest coverage in Aurora, Denver, Edgewater, Englewood, and Fort Collins. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Dreamt concentrated 87.99% of July 2026 sales in Edible, with Tincture & Sublingual at 12.01%, indicating a skew that widened YoY but tightened MoM. Edible grew 36.45% YoY while Tincture & Sublingual fell 23.94% YoY, yet MoM Edible declined 26.94% as Tincture & Sublingual rose 76.62%, implying a short-term rebalancing under a long-term Edible-led trajectory. With overall brand sales up 23.78% YoY and the average price down 23.91%, the mix shift suggests volume-led gains concentrated in Edible even as July 2026 momentum tilted toward Tincture & Sublingual; the thesis is that Dreamt’s category reliance is still Edible, but short-cycle demand is rotating toward higher-priced sublingual formats.
Average price at $12.49 alongside a 20.64 average in Tincture & Sublingual points to a two-tier strategy where Edible drives share while sublingual lifts revenue density, reinforced by a 76.62% MoM surge that contrasts with a 26.94% MoM drop in Edible. The 36.45% YoY rise in Edible against a 23.94% YoY decline in Tincture & Sublingual indicates brand equity is anchored in Edible, but the near-term pivot suggests testing for margin recovery via higher-priced SKUs; the thesis is that Dreamt can defend its Edible base while selectively expanding sublingual to buffer price compression and stabilize the 23.78% YoY sales growth.
Competitive Landscape
Dreamt ranks #50 in NJ Edible in July 2026, unchanged year over year at #50, after improving 3 ranks from #53 in April 2026 and retreating 9 positions from its March 2026 peak at #41; this flat YoY rank alongside a quarter-on-quarter lift implies a narrow rebound that has not yet reset its earlier spring high. At the top of the board, Gron / Grön held #1 year over year despite a -15.0% YoY sales change, while Wyld climbed directionally from #3 to #2 with +2.6% YoY sales growth, a contrast that signals incumbents can maintain or improve rank even amid mixed sales trajectories; for Dreamt, the combination of a stationary YoY rank at #50 and a 3-position rise since April 2026 points to stability at the lower tier rather than momentum back toward its March 2026 peak.
Notable Products
Honey Lemon Gummies 2-Pack (20mg) posted the largest move in July 2026 with a 93.2% month-over-month increase to rank 3, while CBD/THC 2.5:1 Sleep Tincture (60mg CBD, 150mg THC, 60ml) surged 76.6% to rank 5. In contrast, CBD/CBN/THC 4:2:1 Midnight Berry Gummies (40mg CBD, 20mg CBN, 100mg THC) fell 32.6% yet held rank 1, and the CBD/THC/CBN 2:5:1 Honey Lemon Gummies 20-Pack (40mg CBD, 100mg THC, 20mg CBN) dropped 39.6% to rank 2. Four of the top six are Edible SKUs, and the 2:5:1 Midnight Berry Soft Lozenges 10-Pack climbed 71.3% to rank 6, indicating momentum is shifting toward lower-count packs and sleep-adjacent formats even as flagship large packs retrench. The mix points to Dreamt leaning into accessible entry sizes and functional sleep cues to stabilize share while premium-count gummies reset around $9.7k at the top.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
